NCT02563106 - A Study of SYN-004 for the Prevention of C.Diff in Patients With a LRTI | Biotech Hunter

Enrollment

413

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions

Clostridium DifficileClostridium Infections

Interventions

DRUG

SYN-004

DRUG

Placebo

Trial Locations (43)

32720

Synthetic Biologics Investigational Site, DeLand

71457

Synthetic Biologics Investigational Site, Będzin

Synthetic Biologics Investigational Site, Debrecen

Synthetic Biologics Investigational SIte, Natchitoches

72205

Synthetic Biologics Investigational Site, Little Rock

90502

Synthetic Biologics Investigational Site, Torrance

Unknown

Synthetic Biologics Investigational Site, Gabrovo

Synthetic Biologics Investigational Site, Kyustendil

Synthetic Biologics Investigational Site, Lovech

Synthetic Biologics Investigational Site, Multiple Locations

Synthetic Biologics Investigational Site, Rousse

Synthetic Biologics Investigational Site, Sevlievo

Synthetic Biologics Investigational Site, Sofia

Synthetic Biologics Investigational Site, Targovishte

Synthetic Biologics Investigational Site, Sherbrooke

Synthetic Biologics Investigational Site, Toronto

Synthetic Biologics Investigational Site, Balassagyarmat

Synthetic Biologics Investigational Site, Budapest

Synthetic Biologics Investigational Site, Veszprém

Synthetic Biologics Investigational Site, Bialystok

Synthetic Biologics Investigational Site, Bochnia

Synthetic Biologics Investigational Site, Bydgoszcz

Synthetic Biologics Investigational Site, Chodzież

Synthetic Biologics Investigational Site, Lodz

Synthetic Biologics Investigational Site, Oława

Synthetic Biologics Investigational Site, Pomorskie

Synthetic Biologics Investigational Site, Siedlce

Synthetic Biologics Investigational Site, Tarnów

SyntheticBiologics Investigational Site, Tychy

Synthetic Biologics Investigational Site, Warszawice

Synthetic Biologics Investigational Site, Arad

Synthetic Biologics Investigational Site, Brasov

Synthetic Biologics Investigational SIte, Bucharest

Synthetic Biologics Investigational Site, Cluj-Napoca

Synthetic Biologics Investigational Site, Oradea

Synthetic Biologics Investigational Site, Otopeni

Synthetic Biologics Investigational Site, Timișoara

Synthetic Biologics Investigational Site, Belgrade

Synthetic Biologics Investigational Site, Čačak

Synthetic Biologics Investigational Site, Gornji Matejevac

Synthetic Biologics Investigational Site, Kragujevac

Synthetic Biologics Investigational Site, Novi Sad

Synthetic Biologics Investigational Site, Užice

All Listed Sponsors

lead

Theriva Biologics, Inc.

INDUSTRY